Renaissance Technologies - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 11 filers reported holding EVAXION BIOTECH A S in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q2 2022$22,000
-75.6%
11,600
-42.8%
0.00%
Q4 2021$90,00020,2700.00%
Other shareholders
EVAXION BIOTECH A S shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 122,000$238,0000.28%
CITIGROUP INC 2,941$6,0000.00%
MORGAN STANLEY 4,296$8,0000.00%
Citadel Advisors 333,100$650,0000.00%
Citadel Advisors 37,300$73,0000.00%
Citadel Advisors 83,586$163,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 192,800$376,0000.00%
CAPTRUST FINANCIAL ADVISORS 339$1,0000.00%
Steward Partners Investment Advisory, LLC 1,000$2,0000.00%
Renaissance Technologies 11,600$22,0000.00%
View complete list of EVAXION BIOTECH A S shareholders